Once daily intravenous (IV) busulfan (Bu) containing preparative regimens for hematopoietic stem cell transplantation (HSCT): Low incidence of Hepatic Veno-Occlusive Disease (HVOD)... by Benn, H., Amin, A., Susan, H.-C., Kramek, D., Janbay, N., Randhawa, D., Nath, R.

Get full text

Relationship of BK viral load in blood and urine with the severity of hemorrhagic cystitis (HC) after hematopoietic stem cell transplantation (HSCT) by Janbay, N., De Bari, V., Manna, P., Visweshwar, N., David, C., Lange, M., Sterrett, J.R., Nath, R.

Get full text

A 32nm low power RF CMOS SOC technology featuring high-k/metal gate by VanDerVoorn, P, Agostinelli, M, Choi, S, Curello, G, Deshpande, H, El-Tanani, M A, Hafez, W, Jalan, U, Janbay, L, Kang, M, Koh, K, Komeyli, K, Lakdawala, H, Lin, J, Lindert, N, Mudanai, S, Park, J, Phoa, K, Rahman, A, Rizk, J, Rockford, L, Sacks, G, Soumyanath, K, Tashiro, H, Taylor, S, Tsai, C, Xu, H, Xu, J, Yang, L, Young, I, Yeh, J, Yip, J, Bai, P, Jan, C

Request full text

Late Onset Hemorrhagic Cystitis (LOHC) Following Stem Cell Transplant (SCT): Risk Factors and Outcomes by Janbay, Nasser, Amin, Albish, Visweshar, N., Ojha, Rakesh, Mohsen, Reyad, Randhawa, Devinderdal, Stives, S., Benn, H., Manna, Pradeep, Nath, Rajneesh

Get full text